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Abstract In acute myelogenous and lymphoid leukemias, rear-
rangements involving the MLL (mixed lineage leukemia) gene
at chromosome 11q23 are frequent. The truncated MLL protein
is fused in-frame to a series of partner proteins. We previously
identi¢ed the formin-binding protein 17 (FBP17) as such an
MLL fusion partner. In this study, we explored in vivo physio-
logical interaction partners of FBP17 using a two-hybrid assay
and found tankyrase (TNKS), an ADP-ribose polymerase pro-
tein involved in telomere maintenance and mitogen-activated
protein kinase signaling. We demonstrate that FBP17 binds
via a special TNKS-binding motif to tankyrase. The physiolog-
ical relevance is indicated by co-immunoprecipitation of endog-
enous proteins in 293T cells.
1 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
The chromosomal region 11q23 containing the MLL
(mixed lineage leukemia) gene locus is frequently involved in
chromosomal translocations associated with hematological
malignancies. MLL functions as the mammalian counterpart
of Drosophila trithorax (trx), which positively maintains the
expression of homeobox genes during development. The
translocations examined so far resulted in an in-frame fusion
of the partner to the N-terminus of MLL. The fusion proteins
retained several functional MLL domains and are assumed to
disrupt critical patterns of homeobox gene expression in he-
matopoietic progenitor cells contributing to either myeloid or
lymphoid acute leukemia [1].
In a case of acute myeloid leukemia showing an ins-
(11;9)(q23;q34)inv(11)(q13q23) we were able to identify the
human formin-binding protein 17 (FBP17) as a novel MLL
fusion protein [2]. The members of the FBP family were iso-
lated several years ago by screening mouse limb bud expres-
sion libraries with a formin-derived probe [3]. Formins are
nuclear phosphoproteins required for proper limb and renal
development. The physiological relevance of this interaction
remains to be proved and in previous experiments we were
unable to demonstrate the interaction between formin and
wild type FBP17 or formin and the leukemic MLL/FBP17
fusion protein [2]. Thus, we speculated that there may be
other interaction partners of FBP17. Herein, we demonstrate
that FBP17 binds to tankyrase (also termed tankyrase 1,
TNKS), a protein with diverse biological functions, e.g. mi-
togen-activated protein kinase signaling in the cytoplasm and
telomere regulation in the nucleus [4,5].
2. Materials and methods
2.1. Cloning, homologous recombination and sequencing
We used polymerase chain reaction (PCR)-based cloning methods
for the production of all fusion constructs. To serve as template for
the FBP17 PCRs we obtained from the Kazusa DNA Research In-
stitute (www.kazusa.or.jp/en/) clone KIAA0554 containing a 5383 bp
cDNA fragment of FBP17. For ampli¢cation of full length FBP17
(wild type, WT, GenBank accession number AF265550) we used
primers FBP17-F1 and FBP17-R1 (Table 1). For functional analyses
truncated constructs were generated by combining the primers F1/R2,
F1/R3 and F2/R1. All PCR reactions were performed with the proof-
reading polymerase Pfu (Stratagene, La Jolla, CA, USA) and a stan-
dard PCR protocol (60‡C annealing, 35 cycles). The cloning of the
fragments into vector pcDNA3.1DV5-His-TOPO (Invitrogen, Carls-
bad, CA, USA) was performed according to the manufacturer’s in-
structions.
For cloning of FBP17 in the pLexA vector we chose a recombina-
tion-based method as described in [6].
The wild type TNKS insert was generated by PCR ampli¢cation of
the full length TNKS cDNA (GenBank accession number AF082556;
primers TNKS-F and TNKS-R, Table 1) from a cDNA clone pro-
vided by T. de Lange and S. Smith. Truncated TNKS constructs (T1
and TS) were obtained by PCR ampli¢cation of the yeast two-hybrid
prey clone insert (primers T1-F/T1-R and TS-F/pB42AD-R respec-
tively; Table 1) and subsequent cloning into pcDNA3.1D-V5-His-
TOPO.
GFP/TNKS and GFP/SNX2 fusions were produced by PCR-based
cloning of the prey plasmid inserts into the pcDNA3.1/NT-GFP-
TOPO vector (Invitrogen) according to the manufacturer’s instruc-
tions. FBP17 was fused to the red £uorescent protein by cloning
into pDsRed1-N1 (Clontech, Palo Alto, CA, USA; restriction sites
used: EcoRI and BamHI).
All constructs were veri¢ed by sequencing using the ABI Prism Dye
Terminator Cycle Sequencing Ready Reaction Kit and an ABI373A
sequencer (ABI Biosystems, Foster City, CA, USA). Further analyses
of the sequences were done with the program OMIGA 2.0 (Oxford
Molecular), BLAST search algorithms (www.ncbi.nlm.nih.gov/blast/)
and the Prosite database at www.expasy.ch/prosite/.
2.2. Mutagenesis
For examination of the putative tankyrase-binding motif of FBP17
we used the QuikChange1 Multi Site-Directed mutagenesis system
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(Stratagene) and primers R577A+D581A and 577del582 (Table 1).
The myc-FBP17-WT construct served as template for the mutagenesis
reaction according to the manufacturer’s instructions.
2.3. Yeast two-hybrid screening
For our yeast two-hybrid library screen we used the Matchmaker
LexA Two Hybrid System (Clontech) with the yeast indicator strain
EGY48[p8op-lacZ]. To serve as bait FBP17 (F1/R1) was fused to the
C-terminus of the LexA DNA-binding domain. We screened a human
kidney cDNA library in vector pB42AD obtained from Clontech and
tested for false positive clones according to the manufacturer’s in-
structions. The identi¢cation of the insert sequences of true positive
clones was done with the help of the BLAST search algorithms.
2.4. Cell culture and transfection
293T cells were cultured in Dulbecco’s modi¢ed Eagle’s medium
containing 4500 mg/l glucose, 862 mg/l L-alanyl-L-glutamine, 110
mg/l Na-pyruvate, 50 000 U/l penicillin, 50 mg/l streptomycin and
10% (v/v) fetal calf serum. The cells were grown in a humidi¢ed in-
cubator at 37‡C and 5% CO2. For transfection we seeded 6U106 cells
in a 100 mm culture dish at least 24 h prior to the procedure. For each
transfection a total amount of 20 Wg DNA was used following a
standard calcium phosphate transfection protocol [7]. The cells were
harvested 48 h after transfection. For microscopy the cells were trypsi-
nized and examined for development of £uorescence in a confocal
laser scanning microscope (Zeiss).
2.5. Preparation of mammalian and yeast cell extracts
We lysed 293T cells using a hypotonic lysis bu¡er (20 mM HEPES
pH 7.5, 10 mM KCl, 0.5 mM EDTA, 0.1% Triton X-100, 10% glyc-
erol, 4 mM dithiothreitol [DTT], 0.5 mM sodium vanadate, 2 mM
NaF, 2 mM phenylmethylsulfonyl £uoride, 4 Wl/ml protease inhibitor
mix [Sigma]). After centrifugation the supernatant representing the
cytosolic fraction was used for co-immunoprecipitations and is desig-
nated the cytoplasmic extract. Yeast cell extracts were produced by a
standard urea/sodium dodecyl sulfate (SDS) protein extraction proto-
col [8].
2.6. Co-immunoprecipitation and Western blotting
Precleared lysates were incubated with 2 Wg polyclonal immunopre-
cipitation antibody (Table 2) for 2.5 h under constant motion at 4‡C
with addition of 30 Wl protein A/G agarose after 1.5 h. Afterwards the
beads were washed seven times with phosphate-bu¡ered saline (PBS)
containing 0.25% bovine serum albumin and 2 mM DTT and one
time with PBS. After centrifugation the supernatant was removed,
leaving about 20 Wl, and a corresponding volume of sample bu¡er
(Pierce, Rockford, IL, USA) was added. The samples were incubated
at 90‡C for 5 min and electrophoresed on an SDS polyacrylamide gel.
The proteins were detected following a standard Western blotting
chemiluminescence protocol (SuperSignal1 West Pico System,
Pierce). For details on detection antibodies used in this study see
Table 2. For stripping blots were incubated with Restore1 Western
Blot stripping bu¡er (Pierce) for 15 min at 37‡C.
3. Results
3.1. Yeast two-hybrid screen
For our yeast two-hybrid experiments we fused residues 48^
2042 of the human FBP17 mRNA sequence (GenBank acces-
sion number AF265550) to the C-terminus of a LexA DNA-
binding domain. The expression of the fusion protein was
con¢rmed by Western blotting showing a strong signal at
the expected molecular weight of 109 kDa (data not shown).
Since FBP17 shows high expression levels in the kidney
(www.kazusa.or.jp/huge/grpage/KIAA0554), we decided to
screen a human kidney cDNA library for interaction partners
of FBP17. We obtained a commercially available library in
which the cDNAs were fused to the C-terminus of a B42
activation domain. The library consisted of 3.5U106 indepen-
dent clones which were screened for LacZ activation. After
5 days of cultivation on induction medium lacking trypto-
phan, histidine, uracil and leucine we picked 288 blue colo-
nies, of which 44 clones were considered true positives. Two
di¡erent sequences were obtained of 450 bp and 2850 bp,
respectively. These plasmids gave a similarly strong positive
result in comparison to various controls (Fig. 1A,B). We iden-
ti¢ed the insert sequences as encoding sorting nexin 2 (SNX2)
[2] and TNKS (GenBank accession number AF082556). Since
the sequences among the various clones were identical, the
clones are probably derived from a single library clone each.
However, the TNKS insert resembled neither the already de-
scribed splicing variant TT7 nor the variant TT9 (GenBank
accession numbers AF082558 and AF082559) but represented
Table 1
Primer sequences (5PC3P)
Forward primer for PCR Reverse primer for PCR
FBP17-F1 aggagctgcgagccggaggagg FBP17-R1 ctaggaatctttggcatttttgtccaaacag
FBP17-R2 ctagtcctgggcgcagttgttgactgtg
FBP17-F2 ggagagtccatgaagacatatgcag FBP17-R3 ctatgaaaggctgttatctgacacagtgcg
TNKS-F atggcggcgtcgcgtcgctctcagcatcatc TNKS-R ctaggtcttctgctctgcggctgttgcggtctggg
T1-F gaattcgcggccgcgtcgactgttg T1-R ttaactcagaatctgctgcactgcttc
TS-F gagagtacacctatacgtacttc pB42-R ggtagacaagccgacaaccttgattgg
Mutagenesis primer for FBP17
R577A+D581A gcgcccaggacgctgagagcccagctggcagttacac 577del582 caactgcgcccaggacagttacacagaggagc
Inserts with restriction sites, myc or FLAG tags were produced by adding a corresponding sequence to the primer.
Table 2
Antibodies used in this study
Antibody Source Used for Manufacturer
Anti-c-myc rabbit polyclonal against c-Myc tag immunoprecipitation Sigma
Anti-c-myc mouse monoclonal, clone 9E10 detection Sigma
Anti-FLAG mouse monoclonal, M2 detection Stratagene
Anti-TNKS goat polyclonal (N-20) immunoprecipitation Santa Cruz
Anti-TNKS rabbit polyclonal (H-350) detection Santa Cruz
Anti-FBP17 rabbit polyclonal antiserum against epitope NH2-KQLESSKRRFERDC-COOH detection Eurogentec
Secondary antibodies
Anti-mouse IgG goat, Fab-speci¢c, HRP conjugate Sigma
Anti-rabbit IgG goat, HRP conjugate Santa Cruz
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Fig. 1. A: Constructs used in the yeast two-hybrid interaction trap.
LexA-BD: DNA-binding domain of the LexA protein, B42-AD: ac-
tivation domain of the B42 protein. B: Two-hybrid screen results,
showing colonies exhibiting FBP17/TNKS interaction in comparison
to positive (FBP17/SNX2) and negative controls (lamin C/TNKS,
p53/TNKS, co-transformations with empty vectors).
Fig. 2. A: Graphical overview of the FBP17 deletion constructs.
Numbers refer to nucleotides in mRNA. B: Co-immunoprecipitation
assays of TNKS with the myc-FBP17 deletion constructs. CE: cyto-
plasmic extracts of transfected 293T cells, IP: immunoprecipitate.
Immunoprecipitation was performed with polyclonal anti-myc anti-
body. Top panel: Veri¢cation of TNKS expression in the cytoplas-
mic extracts with anti-TNKS antibody at approx. 150 kDa. Middle
panel: TNKS detection with anti-TNKS in immunoprecipitates.
Strong signal of TNKS in the FBP17 wild type (WT) immunopreci-
pitate and a weaker TNKS signal in the F2/R1 immunoprecipitate.
No TNKS signal in the F1/R2 and F1/R3 immunoprecipitates. No
signal in the immunoprecipitate of the solely TNKS-transfected cells
(neg. control). Bottom panel: Con¢rmation of the correct myc-
FBP17 construct expression and immunoprecipitation with anti-myc
antibody. Molecular weights of the constructs: WT=73 kDa, F1/
R2= 62 kDa, F1/R3= 38 kDa, F2/R1= 42 kDa.
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exons 2^23 (encoding aa 231^1051) of tankyrase. The wild
type tankyrase protein contains an ankyrin repeat region (aa
205^943), a sterile K module (aa 1030^1089) with the ability to
mediate both homotypic and heterotypic protein^protein in-
teractions [9] and a poly(ADP-ribose) polymerase (PARP)
domain (aa 1176^1327) [10] (Fig. 3A).
3.2. Veri¢cation of the interaction
The interactions were veri¢ed by co-immunoprecipitations.
FBP17 was tagged at its N-terminus with a myc epitope
(NH2-EQKLISEEDL-COOH). In all cases the expression
was driven by a cytomegalovirus promoter. The constructs
were transfected into 293T cells. Myc-FBP17 was isolated
from cytoplasmic extracts with a polyclonal anti-myc anti-
body. Only in samples of cells co-transfected with FBP17
and TNKS was the TNKS protein detectable at approxi-
mately 150 kDa, whereas the control transfection solely with
FLAG-TNKS showed no signal in the corresponding area.
Correct expression of myc-FBP17 at 73 kDa was con¢rmed
by probing with monoclonal anti-myc antibody (Fig. 2B, left
lane).
3.3. Involvement of the protein domains in the interaction
For a more precise identi¢cation of the domains involved in
the FBP17/TNKS interaction we produced a series of FBP17
deletion mutants. The ¢rst mutant, termed myc-FBP17 F1/
R2, contained nucleotides 48^1730 of the mRNA sequence
and therefore represented FBP17 without its SH3 domain
leading to the expression of a 62 kDa protein. The second,
myc-FBP17 F1/R3, consisted of residues 48^1091, producing
a FBP17 protein lacking the SH3 domain as well as the pu-
tative rho-binding domain with an apparent molecular weight
of 38 kDa. The third mutant, myc-FBP17 F2/R1, contained
residues 870^2042 representing FBP17 without the N-terminal
Cdc15 homology domain, producing a 42 kDa protein (Fig.
2A). After co-transfection with TNKS in 293T cells only wild
type FBP17 and construct F2/R1 gave positive results in the
co-immunoprecipitation assay, although construct F2/R1 was
poorly expressed (Fig. 2B). Thus, the C-terminal part of
FBP17 is necessary for its binding to tankyrase.
The regions of tankyrase responsible for the interaction
were examined by bisecting tankyrase. The fragments repre-
sented aa 231^639 (T1) and aa 640^1051 (TS) of the wild type
protein (Fig. 3A) and after co-transfection only fragment T1
was able to bind FBP17 (Fig. 3B). Since the ankyrin repeats in
tankyrase are organized in clusters [11], fragment T1 contains
the complete ankyrin repeat cluster II and parts of clusters I
and III.
3.4. Mutational analysis of the tankyrase-binding motif
Closer examination of the C-terminus of FBP17 revealed a
putative tankyrase-binding motif (RxxPDG) also present in
the known tankyrase interaction partners IRAP, TAB182,
the telomeric repeat-binding factor-1 (TRF1) and slightly var-
ied in Mcl-1 [12,13]. In FBP17 this motif is located at nucleo-
tides 1729^1746 encoding RESPDG. Site-directed mutagenesis
produced the mutants AESPDG (R577A), AESPAG
(R577A+D581A) and a deletion mutant lacking the binding
motif (577del582). After co-transfection with tankyrase only
wild type FBP17 was able to bind tankyrase in the co-immu-
noprecipitation assay e⁄ciently. The point mutations im-
Fig. 3. A: Schematic representation of tankyrase wild type protein,
the shortened tankyrase found in our library screen and the tanky-
rase deletion constructs T1 and TS. PARP=PARP domain,
HPS=histidine-, proline-, serine-rich domain, SAM=sterile K mod-
ule, ARC: ankyrin repeat cluster. B: Co-immunoprecipitations of
TNKS deletion constructs with myc-FBP17. CE: cytoplasmic ex-
tracts of transfected 293T cells; IP: immunoprecipitate. Immunopre-
cipitation was performed with polyclonal anti-myc antibody. Upper
panel: Detection of TNKS constructs with anti-FLAG antibody.
Only construct T1 is detectable in the myc-FBP17 immunoprecipi-
tate of the cotransfected cells. Lower panel: Con¢rmation of the
correct myc-FBP17 expression and immunoprecipitation with anti-
myc antibody at 73 kDa.
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paired the binding abilities and deletion of the RESPDG mo-
tif completely abolished the interaction (Fig. 4A).
3.5. Interaction of endogenous FBP17 and TNKS
To test whether FBP17 and TNKS interact in their phys-
iological context we performed a co-immunoprecipitation as-
say by immunoprecipitating endogenous TNKS from the cy-
toplasmic extracts of human embryonic kidney 293T cells.
Detection of FBP17 with a speci¢c antiserum was possible
only in the cytoplasmic extracts and the tankyrase immuno-
precipitate but not in the negative control without precipita-
tion antibody (Fig. 4B).
3.6. Con¢rmation of the cytoplasmic localization of FBP17 and
TNKS in the cell
To con¢rm the cytoplasmic localization of FBP17 and
TNKS as well as SNX2 (positive control) in the cell, we trans-
fected 293T cells with DsRed/FBP17 and GFP/TNKS or
GFP/SNX2 fusion constructs. Seventy-two hours after trans-
fection 293T cells showed strong expression of the £uorescent
fusion proteins in the laser scanning confocal microscope. All
proteins tested were localized exclusively in the cytoplasm, as
has previously been reported for exogenously expressed tank-
yrase [14]. After overlay a localization of the proteins at the
margin of the cytoplasm was observed (Fig. 5).
4. Discussion
In previous studies, FBP17, an MLL fusion partner in acute
leukemias, was found to interact with the sorting nexin SNX2
[2,3,15], a molecule that co-immunoprecipitates with the re-
ceptor tyrosine kinases for epidermal growth factor, platelet-
derived growth factor and insulin [16]. Herein, we extend
these observations and report that FBP17 also interacts with
tankyrase, a protein that has di¡erent functions in both the
nucleus and the cytoplasm where the majority of tankyrase
molecules can be found [4,10,13]. This interaction was medi-
ated by an RESPDG hexapeptide in FBP17 that is retained in
the MLL/FBP17 fusion protein found in leukemias. The phys-
iological relevance of these ¢ndings was emphasized by the
demonstration of an interaction between endogenous FBP17
and cytoplasmic tankyrase (Fig. 4B).
Wild type FBP17, like several other MLL fusion proteins,
e.g. AF6, MSF or hCDCrel, is physiologically localized in the
cytoplasm [2,17^19]. After its fusion to MLL, the chimeric
MLL/FBP17 oncoprotein is found in the nucleus [2]. It has
therefore been hypothesized that MLL fusion partners might
lose their physiological binding partners and that this process
contributes to leukemogenesis. As long as the exact function
of cytoplasmic tankyrase is unclear, such a role for the
FBP17^tankyrase interaction remains speculative.
Tankyrase belongs to the ankyrin protein family, whose
6
Fig. 4. A: Co-immunoprecipitation assay of TNKS with wild type
myc-FBP17 and FBP17 constructs with mutated tankyrase-binding
motif. Top panel: Veri¢cation of TNKS expression in the cytoplas-
mic extracts (CE) of transfected 293T cells with anti-TNKS at ap-
prox. 150 kDa. Middle panel: TNKS detection in FBP17 immuno-
precipitates (IP). Immunoprecipitation was performed with
polyclonal anti-myc antibody. TNKS binds to wild type FBP17 and
much more weakly to the D581A mutant containing one point mu-
tation in the binding motif. Introduction of a second point mutation
(R577A+D581A) impairs the binding even more. Deletion of the
binding motif (577del582) abolishes the binding completely. Bottom
panel: Con¢rmation of equal FBP17 immunoprecipitation with anti-
myc. No signal in the solely TNKS-transfected negative control.
B: Co-immunoprecipitation of endogenous FBP17 by TNKS.
TNKS was immunoprecipitated with a polyclonal anti-TNKS anti-
body from cytoplasmic extracts of 293T cells. FBP17 was detected
with an anti-FBP17 antiserum in the cytoplasmic extract (CE) as
well as in the immunoprecipitation (IP) but not in the negative con-
trol (IP without anti-TNKS).
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members function as linkers that couple diverse proteins via
ankyrin motifs to the underlying cytoskeleton [20^22]. This
family is characterized by tandem repeats of a 33 aa motif
(ANK repeats). Tankyrase possesses 24 ANK repeats as well
as a sterile K module, responsible for protein^protein interac-
tions, and a PARP homology domain [10]. All known tank-
yrase interaction partners (TRF1, IRAP, TAB182 and Mcl-1)
bind to the ankyrin repeat domain which is organized in ¢ve
repeat clusters separated by highly conserved LLeaaK/R mo-
tifs. The fact that the partners are able to bind to overlapping
ankyrin repeats suggests a competition between the di¡erent
interacting proteins with regulative potential [4,10,11,13,23].
The PARP domain enables tankyrase to ADP-ribosylate
itself and speci¢c substrates like TRF1 [10,11]. Thus, tank-
yrase is involved in proper regulation of human telomere
maintenance. A recently described tankyrase 2, which is
highly homologous to tankyrase, lacks the N-terminal histi-
dine-, proline- and serine-rich domain (HPS) but shows a very
similar behavior to tankyrase, with which it is able to oligo-
merize [24^26]. In addition two splicing variants of tankyrase
have been described (GenBank accession numbers AF082558
and AF082559), both lacking the sterile K module and the
PARP domain and therefore probably limited in their regu-
lative abilities. The truncated protein discovered in our library
screen also lacks the PARP and HPS domains, indicating that
these domains are dispensable for the interaction with FBP17.
The absence of intrinsic PARP activity abolishes the ADP-
ribosylation capabilities of tankyrase and therefore impairs
the regulation of telomeric function [10].
In addition tankyrase might also exhibit a role in regulation
of cell survival and apoptosis. As has been shown recently
tankyrase down-regulates Mcl-1 protein expression, an anti-
apoptotic Bcl-2 protein family member. Of special note, the
down-regulation of Mcl-1 proteins by tankyrase does not de-
pend on ADP-ribosylation [13].
In further studies the mode of interaction between tanky-
rase and FBP17 should be examined. FBP17 could serve as a
poly(ADP-ribosyl)ation substrate for tankyrase or mediate
secondary interactions with substrates or e¡ectors. In sum,
these data provide a link between an MLL fusion partner
and a possible deregulation of telomere function and/or apo-
ptosis in human cells.
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